论文部分内容阅读
目的观察双歧杆菌四联活菌片联合黄连素治疗腹泻型肠易激综合征的疗效和安全性。方法将64例腹泻型肠易激综征患者分为两组,每组病例32例,治疗组为双歧杆菌四联活菌片联合黄连素;对照组为黄连素,治疗2周后进行疗效对比。结果联合治疗组总有效率为93.75%。对照组总有效率为68.75%。联合治疗组总有效率明显优于对照组(P<0.05)。两组患者均未发现明显不良反应。结论双歧杆菌四联活片联合黄连素治疗腹泻型肠易激综合征安全有效,值得进一步临床推广使用。
Objective To observe the efficacy and safety of live bifidobacterium tetani combined with berberine in the treatment of diarrhea-predominant irritable bowel syndrome. Methods Sixty-four patients with diarrhea-predominant irritable bowel syndrome were divided into two groups, 32 cases in each group. The treatment group was Bifidobacterium quadricepsillum combined with berberine. The control group was berberine, and the effect was observed after 2 weeks of treatment Compared. Results The total effective rate of combination therapy group was 93.75%. The total effective rate of the control group was 68.75%. The total effective rate of the combined treatment group was significantly better than that of the control group (P <0.05). No significant adverse reactions were found in both groups. Conclusion Bifidobacterium quadruple tablets combined with berberine for the treatment of diarrhea-predominant irritable bowel syndrome is safe and effective, which is worth further clinical use.